JPX · —

SUS Co.,Ltd. (6554.T) Stock

$1102.00 +1.47% JPX: 6554.T —

—

Valuation

MetricValue
Price$1102.00
Market Cap—
P/E Ratio—
P/B Ratio—
P/S Ratio—
EPS (TTM)—
52-Week High$1260.00
52-Week Low$946.00
Dividend Yield—

Financials & Margins

MetricValue
ROE—
ROA—
ROCE—
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity—
Current Ratio—

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield—
Quick Ratio—
Interest Coverage—
Return 1Y-1.02%
Return 3Y54.78%
Return 5Y204.10%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
3004.TShinyei Kaisha $1993.00 -1.97% 13.83 $7.89B 5.46%
3353.TMedical Ikkou Group Co.,Ltd. $2770.00 -1.00% 7.23 $10.55B 4.29%
3420.TKFC Ltd $1540.00 -0.52% 8.82 $11.31B 4.53%
3512.TNippon Felt Co., Ltd. $1035.00 +2.37% 26.88 $16.64B 2.75%
6560.TLTS, Inc. $1724.00 -3.15% 8.17 $7.75B 2.25%

About SUS Co.,Ltd.

—

SUS Co.,Ltd. is led by CEO Kimio Saito, employs 2,409 people, headquartered in Kyoto, JP, publicly traded since 2017.

over the past 52 weeks the stock has ranged between $946.00 and $1260.00, and currently trades 12.5% below its 52-week high.

Official website: www.sus-g.co.jp

SUS Co.,Ltd. (6554.T) — frequently asked questions

What is SUS Co.,Ltd. (6554.T) stock price today?

SUS Co.,Ltd. (6554.T) is currently trading at $1102.00, up 1.47% today.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% EROC ERock, Inc. $8.28 -12.01% PSQL Pasqal Holding SA $5.65 -8.28% SGP SpyGlass Pharma, Inc. $28.22 +1.84% FCBM First Carolina Financial Services, Inc. $12.91 +1.89% KPET KPET Ultra Paceline Corporation $10.12 +1.20% SHOT RMG ML Sports Holdings $9.88 +0.10% GOW GOWell Energy Technology $3.30 -8.33% QMLS QumulusAI, Inc. $3.41 -8.33%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.